Actively Recruiting
A Study of Olanzapine in Participants With Bipolar Disorder.
Led by Boryung Pharmaceutical Co., Ltd · Updated on 2025-12-04
3000
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aimed to identify treatment patterns in patients with bipolar disorder receiving olanzapine according to demographic and clinical characteristics and to evaluate the effectiveness of education on weight gain, a side effect of olanzapine, in preventing weight gain.
CONDITIONS
Official Title
A Study of Olanzapine in Participants With Bipolar Disorder.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who have signed informed consent after learning about the study.
- Patients diagnosed with bipolar disorder and scheduled to take olanzapine.
- Patients who understand the survey and can answer questions themselves.
You will not qualify if you...
- Female patients who are pregnant, breastfeeding, or can become pregnant.
- Patients who have used investigational products within 12 weeks before the study or plan to join another clinical trial during this study.
- Patients considered unsuitable for the study by the investigator.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHA Bundang Medical Center
Seongnam, South Korea
Actively Recruiting
Research Team
S
Shinyoung Oh
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here